Combined therapy of somatostatin analogues with pegvisomant for the treatment of acromegaly: a meta-analysis of prospective studies

BACKGROUND: Acromegaly is a rare, chronic and severe disease. Drug therapy including somatostatin analogues (SAs), dopamine receptor agonists and growth hormone receptor antagonists (pegvisomant, PEG) are commonly used to treat patients who do not respond to surgery. The use of combination therapy w...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Lingyun, Luo, Daohuang, Yang, Ting, Wu, Songtao, Li, Min, Chen, Chaoyang, Zhou, Shuang, Ma, Lingyue, Wu, Ye, Zhou, Ying, Cui, Yimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433060/
https://www.ncbi.nlm.nih.gov/pubmed/32811475
http://dx.doi.org/10.1186/s12902-020-0545-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433060/
https://www.ncbi.nlm.nih.gov/pubmed/32811475
http://dx.doi.org/10.1186/s12902-020-0545-2

Ejemplares similares